Healthcare workers told Norman G. Einspruch (88), a heart disease patient, as part of a COVID-19 vaccination program for the elderly at Jackson Memorial Hospital in Miami, Florida, on December 30, 2020. Inoculate the BioNTech vaccine.
Marco Bello | Anadolu Agency | Getty Images
High-risk groups, such as the elderly and people with underlying illness, are expected to get booster shots first. Pfizer—BioNTech The company’s chief scientific officer, Covid-19 Vaccine, told investors Tuesday.
The double-dose vaccine has been shown to be about 95% effective against Covid two weeks after the second vaccination, but researchers have shown. Someone who helped develop the shot Now they say they are beginning to see strong protection waning over time.
Pfizer and BioNTech executives have previously told CNBC that a booster or third dose of the Covid-19 vaccine may be required within 12 months of being fully vaccinated. They also said that people are likely to need to get additional shots each year.
Pfizer’s Chief Scientific Officer Michael Dorsten said Tuesday’s earnings announcement for seniors, cardiovascular disease and asthma.
“We can’t predict what the CDC and FDA will do,” he added.
Dorsten’s comments came after the company reported: Sale of Covid-19 vaccine It boosted performance in the first quarter.
The company now expects annual revenue from vaccines to be $ 26 billion, up from previous forecasts of about $ 15 billion. Adjusted pre-tax profit is expected in the high range of 20% of vaccine revenue.
Pfizer CEO Albert Bourla told investors in a earnings announcement.
If Americans need booster shots, the US government will need to make arrangements with pharmaceutical companies to supply additional doses and plan vaccine distribution.
Last month, Presidential Adviser Andy Slavit Joe BidenThe Covid-enabled team at the White House Prepare for potential needs For Covid-19 vaccine booster shots. He said the Biden administration is thinking about the need to secure additional doses.
Pfizer expects healthy older people to be the first
Source link Pfizer expects healthy older people to be the first